#Lunit 328130 | Stock channels

Lunit328130

₩11,270-2.09%Close Oct 22

This is the start of #Lunit

Talk about Lunit here. Pull up price, chart, news and filings just for you from the message box, or mention @InverseOneBot to get an answer everyone can see.

InverseOne BotBOTOnly visible to you

Welcome to the Lunit channel. Here's the latest data.

루닛 328130

Close as of Oct 22

₩11,270-2.09%

Low ₩8,18052-week rangeHigh ₩24,550

At a glance: 19% of the 52-week range, estimated net outflow for 3 sessions in a row, lending balance growing, filing check: Quiet.

Disappears when you reload.

루닛 328130

Close as of Oct 22

₩11,270-2.09%

Low ₩8,18052-week rangeHigh ₩24,550

5 sessions

+2.1%

20 sessions

+27.5%

60 sessions

+14.5%

Volume

0.5x average

Price

Apr 10 ~ Oct 22

₩11,270-39.32%

Low ₩8,210High ₩22,300

Money flow

as of Oct 22

Strong outflow index-₩139.3M

Net flow, Outflow

Market flow rank: Outflow #52 of 57
Sector flow rank: #4 of 13

Today's overlaps

Loan balance building + outflow index

Multi-day trend, Persistent outflow

Cumulative flow: +₩1.3B
outflow: 3d streak

Estimated from public price, change and volume. Not actual investor net buying.

as of Oct 22

PBR

2.53

Market cap

₩839.1B

Lending balance

Building

9,112,960 sh

KRW 0.10T

1D +11.37%5D +35.50%

New 971,674 sh, Returned 41,012 sh

Shares borrowed through securities lending that have not yet been returned. Borrowed shares are often sold afterwards, so the balance is used as a reference for pending sell pressure.

As of 2026-10-22, FSC stock lending data

Filing check

Quiet0 to check first, 0 improvementschecked through Oct 23

This only counts facts confirmed in filings. It does not look at whether the price is cheap or expensive, and it is not a reason to buy or sell on its own.

Earnings quality

We read the latest periodic report and check whether profit matches cash, sales match receivables, and profit from the core business matches profit from elsewhere. There is no score, only the numbers that diverge beyond a threshold and why they matter.

2026 first half, consolidated statements, filed 2026-08-11

No numbers diverge beyond the threshold

No divergence does not mean the results are good.

Net profit and operating cash flow
Net profit -414억 원, operating cash flow -218억 원
Net profit is a loss, so no ratio is calculated.
Profit from outside the core business
Pretax profit -405억 원, operating profit -290억 원, non-operating result -115억 원
Pretax result is a loss, so no share is calculated.

Source filing: 2026 first half Report a year earlier

This only checks whether the statement numbers agree with each other. It ignores the share price and is not a reason to buy or sell on its own. See the formula

Sector moves

Of 13 covered Healthcare stocks in Korean, 12 fell; the average change was -2.68%. Lunit moved in the same direction at -2.09%. Estimated sector flow was outflow.

Variables to watch Drug approvals and trial results, Drug pricing policy, US interest rates, USD/KRW

Risks to check -77% below the high, the downtrend may continue, Clinical trial failure, Drug pricing pressure

Same-sector channels

Latest news

Stock page

Posts are members' opinions. Investment decisions and their consequences are your own.

Data: KRX daily bars, InverseOne quote snapshots, public news feeds, DART filings, InverseOne company research. Not a call to buy or sell.